Background
The goal of our proposal is to identify new therapeutic targets for one of the most aggressive childhood sarcomas - malignant rhabdoid tumors. These dreadful tumors typically strike infants and young children. Chemotherapy and radiation are rarely curative and no other effective treatment is currently available. As a result, the majority of children with this type of tumor expire within the first year of diagnosis.
